ArticleProbiotics and antimicrobial proteins2026
Antimicrobial Peptide BSN-37 Enhances Macrophage Immune Activation Through the circBptf-Rbm14-Mediated Regulatory Axis.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Antimicrobial peptides (AMPs) are increasingly recognized as regulators of immune cell function, yet whether they engage nuclear regulatory circuits to control macrophage activation remains unclear. Here, we report that the bovine cathelicidin BSN-37 promotes macrophage immune activation through a regulatory mechanism associated with the nuclear circRNA circBptf and the RNA-binding protein Rbm14. Transcriptomic profiling revealed that BSN-37 markedly remodels the circRNA landscape and consistently suppresses circBptf, a circular RNA derived from the chromatin-regulatory Bptf locus. circBptf is a stable nuclear RNA that functions as a negative regulator of macrophage activation, limiting cytokine production and antigen-presentation-related molecules. Mechanistically, circBptf physically associates with the nuclear RNA-binding protein Rbm14, a transcriptional co-regulator linked to immune gene expression. Functional perturbation analyses indicate that circBptf overexpression suppresses macrophage activation, whereas Rbm14 promotes the expression of cytokines and antigen-presentation-related molecules. Functional rescue experiments further support a circBptf-Rbm14-associated regulatory module involved in BSN-37-induced macrophage activation. Together, these findings support a nuclear circRNA-RBP-associated regulatory module linking an antimicrobial peptide to circRNA-mediated control of transcription and identify circBptf as a negative regulatory component of macrophage activation. This work expands the understanding of AMP-mediated immunoregulation by revealing how noncoding RNA-protein interactions contribute to coordinated immune gene expression.
Indexed as
Identifiers
42603258What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.